Evidence map›Paper›PMID 31978422›Full record

ArticleProgress in neuro-psychopharmacology & biological psychiatry2020

Dose-dependent induction of CPP or CPA by intra-pVTA ethanol: Role of mu opioid receptors and effects on NMDA receptors.

Yolanda Campos-Jurado, Lucía Martí-Prats, Jose A Morón, Ana Polache, Luis Granero, Lucía Hipólito

Open access · greenAbstract read
In one paragraph

Article in Progress in neuro-psychopharmacology & biological psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yolanda Campos-JuradoDepartment of Pharmacy and Pharmaceutical Tech. and Parasit., University of València, Spain.
Lucía Martí-PratsDepartment of Pharmacy and Pharmaceutical Tech. and Parasit., University of València, Spain.
Jose A MorónDepartment of Anesthesiology, Washington University Pain Center, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA; Department of Neuroscience, Washington University in St. Louis, St. Louis, MO 63110, USA.
Ana PolacheDepartment of Pharmacy and Pharmaceutical Tech. and Parasit., University of València, Spain.
Luis GraneroDepartment of Pharmacy and Pharmaceutical Tech. and Parasit., University of València, Spain.
Lucía HipólitoDepartment of Pharmacy and Pharmaceutical Tech. and Parasit., University of València, Spain. Electronic address: Lucia.hipolito@uv.es.
Universitat de València · ESWashington University in St. Louis · US

Funding

Dissecting circuits mediating pain-induced alterations in motivated behaviorR01DA041781 · NIDA · WASHINGTON UNIVERSITY · PI MORON-CONCEPCION, JOSE A · 2017 to 2021
$2.3M
Role of SK2 channels in morphine dependenceR01DA042499 · NIDA · WASHINGTON UNIVERSITY · PI MORON-CONCEPCION, JOSE A · 2017 to 2021
$1.9M
Defining a role for kappa opioid system in affective behavior and drug escalation in painR01DA045463 · NIDA · WASHINGTON UNIVERSITY · PI MORON-CONCEPCION, JOSE A · 2018 to 2022
$1.8M
USING TRANSGENIC MICE TO EXAMINE THE ROLE OF CNIH3 VARIANTS IN OPIOID DEPENDENCER33DA041883 · NIDA · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MORON-CONCEPCION, JOSE A · 2018 to 2020
$1.1M
In vivo imaging of dynamic structural plasticity driving morphine conditioned place preferenceR21DA042581 · NIDA · WASHINGTON UNIVERSITY · PI HAN, EDWARD BING, MORON-CONCEPCION, JOSE A · 2016 to 2017
$381k
USING TRANSGENIC MICE TO EXAMINE THE ROLE OF CNIH3 VARIANTS IN OPIOID DEPENDENCER21DA041883 · NIDA · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MORON-CONCEPCION, JOSE A · 2016 to 2017
$379k
NIDA NIH HHS R01 DA041781NIDA NIH HHS R01 DA042499NIDA NIH HHS R01 DA045463NIDA NIH HHS R21 DA041883NIDA NIH HHS R21 DA042581NIDA NIH HHS R33 DA041883
6 · The paper itself

Abstract

The neurobiological mechanisms underlying alcohol motivational properties are still not fully understood, however, the mu-opioid receptors (MORs) have been evidenced as central elements in the manifestation of the alcohol reinforcing properties. Drug-associated environmental stimuli can trigger alcohol relapse and promote alcohol consumption whereby N-methyl-d-aspartate (NMDA) receptors play a pivotal role. Here we sought to demonstrate, for the first time, that ethanol induces conditioned place preference or aversion (CPP or CPA) when administered locally into the ventral tegmental area (VTA) and the associated role of MORs. We further analyzed the changes in the expression and mRNA levels of GluN1 and GluN2A subunits in designated brain areas. The expression of CPP or CPA was characterized following intra-VTA ethanol administration and we showed that either reinforcing (CPP) or aversive (CPA) properties are dependent on the dose administered (ranging here from 35 to 300 nmol). Furthermore, the critical contribution of local MORs in the acquisition of CPP was revealed by a selective antagonist, namely β-Funaltrexamine. Finally, modifications of the expression of NMDA receptor subunits in the Nucleus Accumbens (NAc) and Hippocampus after ethanol-induced CPP were analyzed at the proteomic and transcriptomic levels by western blot and In Situ Hybridation RNAscope techniques, respectively. Results showed that the mRNA levels of GluN2A but not GluN1 in NAc are higher after ethanol CPP. These novel results pave the way for further characterisation of the mechanisms by which ethanol motivational properties are associated with learned environmental cues.

Indexed as

AnimalsAvoidance LearningConditioning, PsychologicalDose-Response Relationship, DrugEthanolInfusions, IntraventricularMaleMicroinjectionsRatsRats, WistarReceptors, N-Methyl-D-AspartateReceptors, Opioid, muVentral Tegmental AreaEthanolReceptors, N-Methyl-D-AspartateReceptors, Opioid, muAlcoholConditioned place preferenceGluN2A mRNAMORsVTA

Identifiers

PMID31978422
PMCPMC7096259
OpenAlexW3001064620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.